Sejong Medical Co., Ltd. announced a private placement of series 1 non-guaranteed private equity convertible bonds with bearer type interest part for gross proceeds of KRW 10,000,000,000, series 2 non-guaranteed private convertible bonds with bearer type interest part for gross proceeds of KRW 10,000,000,000 and 1,355,548 common shares at a price of KRW 9,220 per share for gross proceeds of KRW 12,498,152,560, for aggregate gross proceeds of KRW 32,498,152,560 on July 23, 2021. The transaction will include participation from new investors K1 Bio Combination 1 for series 1 bonds, H Bio Association 1 for series 2 bonds, and Time Investment Co., Ltd for common shares. The common shares have a face value of KRW 500 per share. The series 1 and series 2 bonds carry yield to maturity rate of 2%, fixed interest rate of 2%, will mature on September 17, 2024, and are fully convertible into 970,591 common shares, representing 14.32% stake in the company, at a fixed conversion price of KRW 10,303 per share, from September 17, 2022 to August 17, 2024. The company will issue securities through 3rd party allocation increase method. The transaction has been approved by board of directors of the company. The payment date for bonds is September 17, 2021 and payment date for common shares is September 10, 2021. The shares to be issued in the transaction will be subject to a lock-up period of 1 year.